Catalyst
Key milestones include safety data release and preliminary efficacy results from the trial.
Date
June 23, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.